{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-058120","form_type":"8-K/A","ticker":"SKYE","cik":"0001516551","company_name":"Skye Bioscience, Inc.","filed_at":"2026-08-20T01:42:34+00:00","discovered_at":"2026-08-20T10:05:00.141910+00:00","generated_at":"2026-08-20T10:05:31.051851+00:00","sec_items":["3.03"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Skye Bioscience reverse stock split effective Aug 24, 2026; ticker stays SKYE","bullets":["Reverse stock split becomes effective at 12:01 am New York time on August 24, 2026.","Common stock begins trading split-adjusted on Nasdaq at market open August 24, 2026, under ticker SKYE.","New CUSIP for post-split common stock is 83086J309.","Amendment confirms effective date of previously disclosed reverse split; no change to ticker symbol."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-058120","json":"https://secwatch.observer/filing/0001628280-26-058120.json","markdown":"https://secwatch.observer/filing/0001628280-26-058120.md","text":"https://secwatch.observer/filing/0001628280-26-058120.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1516551/000162828026058120/0001628280-26-058120-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1516551/000162828026058120/skye-20260812.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-20T10:05:31.051851+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}